SG11201909214YA - System and process for treatment of myopia - Google Patents

System and process for treatment of myopia

Info

Publication number
SG11201909214YA
SG11201909214YA SG11201909214YA SG11201909214YA SG 11201909214Y A SG11201909214Y A SG 11201909214YA SG 11201909214Y A SG11201909214Y A SG 11201909214YA SG 11201909214Y A SG11201909214Y A SG 11201909214YA
Authority
SG
Singapore
Prior art keywords
international
myopia
california
eye tissue
ojai
Prior art date
Application number
Inventor
Jeffrey K Luttrull
David B Chang
Benjamin W L Margolis
Original Assignee
Ojai Retinal Technology Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/583,096 external-priority patent/US10953241B2/en
Priority claimed from US15/629,002 external-priority patent/US10278863B2/en
Application filed by Ojai Retinal Technology Llc filed Critical Ojai Retinal Technology Llc
Publication of SG11201909214YA publication Critical patent/SG11201909214YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0622—Optical stimulation for exciting neural tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0625—Warming the body, e.g. hyperthermia treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/067—Radiation therapy using light using laser light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0001—Body part
    • A61F2007/0002—Head or parts thereof
    • A61F2007/0004—Eyes or part of the face surrounding the eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
    • A61F2009/00863—Retina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0642—Irradiating part of the body at a certain distance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared

Abstract

Title: SYSTEM AND PROCESS FOR TREATMENT OF MYOPIA 30 32 34 FIG. 3 ................. ........ .......... 38 (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 08 November 2018 (08.11.2018) iii111111110111010100111110l0 01010111100111111101110 011 (10) International Publication Number WO 2018/203930 Al WIPO I PCT (51) International Patent Classification: A61B 17/00 (2006.01) A61B 18/12 (2006.01) A61B 18/00 (2006.01) A61B 18/18 (2006.01) A61B 18/04 (2006.01) A61B 18/20 (2006.01) (21) International Application Number: PCT/US2017/064708 (22) International Filing Date: 05 December 2017 (05.12.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 15/583,096 01 May 2017 (01.05.2017) US 15/629,002 21 June 2017 (21.06.2017) US (71) Applicant: OJAI RETINAL TECHNOLOGY, LLC [US/US]; 283 Came Road, Ojai, California 93023 (US). (72) Inventors: LUTTRULL, Jeffrey K.; 283 Came Road, Ojai, California 93023 (US). CHANG, David B.; 14212 Livingston, Tustin, California 92780 (US). MARGOLIS, Benjamin W. L.; 2879 MacArthur Blvd, Oakland, Califor- nia 94602 (US). (74) Agent: KELLEY, Scott W.; Kelly & Kelley, LLP, 6320 Canoga Avenue, Suite 1650, Woodland Hills, California 91367 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, cr O 00 O C (57) : A process for preventing or treating myopia includes applying a pulsed energy, such as a pulsed laser beam, to tissue of an eye having myopia or a risk of having myopia. The source of pulsed energy has energy parameters including wavelength or frequency, duty cycle and pulse train duration, which are selected so as to raise an eye tissue temperature up to eleven degrees Celsius to achieve therapeutic or prophylactic effect, such as stimulating heat shock protein activation in the eye tissue. The average temperature rise of the eye tissue over several minutes is maintained at or below a predetermined level so as not to permanently damage the eye tissue. [Continued on next page] WO 2018/203930 Al MIDEDIMOMOIDEIRDERI001010111001fiMODEVOIS TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3))
SG11201909214Y 2017-05-01 2017-12-05 System and process for treatment of myopia SG11201909214YA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/583,096 US10953241B2 (en) 2012-05-25 2017-05-01 Process for providing protective therapy for biological tissues or fluids
US15/629,002 US10278863B2 (en) 2016-03-21 2017-06-21 System and process for treatment of myopia
PCT/US2017/064708 WO2018203930A1 (en) 2017-05-01 2017-12-05 System and process for treatment of myopia

Publications (1)

Publication Number Publication Date
SG11201909214YA true SG11201909214YA (en) 2019-11-28

Family

ID=64016725

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201909214Y SG11201909214YA (en) 2017-05-01 2017-12-05 System and process for treatment of myopia

Country Status (8)

Country Link
EP (1) EP3618923A4 (en)
JP (2) JP2020518317A (en)
CN (1) CN110582238A (en)
AU (1) AU2017412681B2 (en)
BR (1) BR112019023061A2 (en)
CA (1) CA3058891A1 (en)
SG (1) SG11201909214YA (en)
WO (1) WO2018203930A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10709608B2 (en) 2016-03-21 2020-07-14 Ojai Retinal Technology, Llc System and process for prevention of myopia
WO2020251609A1 (en) * 2019-06-13 2020-12-17 Ojai Retinal Technology, Llc System and process for prevention of myopia
CN112386806A (en) * 2020-10-10 2021-02-23 深圳敬中堂科技有限公司 Light source combination for correcting visual diseases related to opsin gene and application
CN113244045A (en) * 2021-07-15 2021-08-13 中山大学中山眼科中心 High-efficiency vision recovery method and equipment

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090100A (en) * 1992-10-01 2000-07-18 Chiron Technolas Gmbh Ophthalmologische Systeme Excimer laser system for correction of vision with reduced thermal effects
US6129722A (en) * 1999-03-10 2000-10-10 Ruiz; Luis Antonio Interactive corrective eye surgery system with topography and laser system interface
US7503655B2 (en) * 2003-11-19 2009-03-17 Vision Crc Limited Methods and apparatuses for altering relative curvature of field and positions of peripheral, off-axis focal positions
CN2817788Y (en) * 2005-07-19 2006-09-20 冯丹藜 Automatic frequency-variable laser amblyopia therapeutic device
US9403029B2 (en) * 2007-07-18 2016-08-02 Visualase, Inc. Systems and methods for thermal therapy
WO2009088550A2 (en) * 2007-10-19 2009-07-16 Lockheed Martin Corporation System and method for conditioning animal tissue using laser light
US8141557B2 (en) * 2008-10-22 2012-03-27 Peyman Gholam A Method of oscillatory thermotherapy of biological tissue
WO2011084863A2 (en) * 2010-01-07 2011-07-14 Cheetah Omni, Llc Fiber lasers and mid-infrared light sources in methods and systems for selective biological tissue processing and spectroscopy
US20130110095A1 (en) * 2011-10-26 2013-05-02 Brian S. Boxer Wachler Method of correcting vision problems using only a photodisruption laser
US9427602B2 (en) * 2012-05-25 2016-08-30 Ojai Retinal Technology, Llc Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair
US10531908B2 (en) * 2012-05-25 2020-01-14 Ojai Retinal Technology, Llc Method for heat treating biological tissues using pulsed energy sources
US10278863B2 (en) * 2016-03-21 2019-05-07 Ojai Retinal Technology, Llc System and process for treatment of myopia
US9333371B2 (en) * 2012-11-01 2016-05-10 Seminex Corporation Variable intensity laser treatments of the skin
CN107205768B (en) * 2015-01-28 2020-06-16 奥海视网膜科技有限公司 Pulsed electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and promoting protein repair
EP3364925B1 (en) * 2015-10-23 2021-12-08 Ojai Retinal Technology, LLC System for retina phototherapy

Also Published As

Publication number Publication date
CA3058891A1 (en) 2018-11-08
WO2018203930A1 (en) 2018-11-08
EP3618923A1 (en) 2020-03-11
AU2017412681A1 (en) 2019-10-31
CN110582238A (en) 2019-12-17
BR112019023061A2 (en) 2020-06-09
AU2017412681B2 (en) 2019-11-14
JP2022184907A (en) 2022-12-13
JP2020518317A (en) 2020-06-25
EP3618923A4 (en) 2020-03-11

Similar Documents

Publication Publication Date Title
SG11201407205WA (en) System and process for retina phototherapy
SG11201909214YA (en) System and process for treatment of myopia
SG11201901714QA (en) Glaucoma treatment methods and apparatus
SG11201909096WA (en) Systems and methods for ocular laser surgery and therapeutic treatments
SG11201809627QA (en) Anti pd-1 and anti-lag3 antibodies for cancer treatment
SG11201811457QA (en) Methods and devices for valve clip excision
SG11201900817XA (en) Systems and methods for delivering an intravascular device to the mitral annulus
SG11201808236YA (en) Method and apparatus for delivery of therapeutic agents
SG11201910019PA (en) Microorganisms and methods for producing cannabinoids and cannabinoid derivatives
SG11201810034XA (en) ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
SG11201811491YA (en) Quinazoline and indole compounds to treat medical disorders
SG11201809850QA (en) Systems and methods for cosmetic ultrasound treatment of skin
SG11201806322QA (en) Maytansinoid derivatives, conjugates thereof, and methods of use
SG11201811019TA (en) Device for cardiac valve repair and method of implanting the same
SG11201909388RA (en) Peel and place dressing for thick exudate and instillation
SG11201909303TA (en) Point of delivery cold slurry generation
SG11201804814YA (en) Materials and methods for delivering nucleic acids to cochlear and vestibular cells
SG11201901271VA (en) Uses of pd-1/pd-l1 inhibitors and/or ctla-4 inhibitors with a biologic containing multiple cytokine components to treat cancer
SG11201903483VA (en) Compositions and methods for treating ezh2-mediated cancer
SG11201808314QA (en) Compositions and methods for the treatment of wounds, disorders, and diseases of the skin
SG11201810515TA (en) Internal ultraviolet therapy
SG11201909927RA (en) Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
SG11201804263PA (en) Cancer treatment using 2-deoxy-2-fluoro-l-fucose in combination with a checkpoint inhibitor
SG11201808306PA (en) Treatment of cancer with tg02
SG11201901566RA (en) Skin treatment apparatus